Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
04/2010
04/07/2010EP2172222A2 Novel BLT2-mediated disease, BLT2-binding agent and compound
04/07/2010EP2172217A1 Fibrosis inhibitor
04/07/2010EP2172206A1 The method for a sequoyitol-containing extract obtaining from the genus of trifolium, sobyean and ginkgo biloba and use thereof
04/07/2010EP2170876A2 Pharmaceutical composition for preventintion and treatment of restenosis comprising isoxazole derivatives
04/07/2010EP2170846A2 Substituted piperazines as cb1 antagonists
04/07/2010EP2170835A1 Process for preparing telmisartan
04/07/2010EP2170831A1 Benzazepine derivatives useful as vasopressin antagonists
04/07/2010EP2170815A2 Renin inhibitors
04/07/2010EP2170401A1 Dendrimer conjugates of agonists and antagonists of the gpcr superfamily
04/07/2010EP2170397A1 Methods and compositions for treating pulmonary hypertension and related diseases and disorders
04/07/2010EP2170364A2 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection
04/07/2010EP2170347A1 Single-phase pharmaceutical composite preparation (dienogest and ethinyl estradiol) for oral therapy for regulation of blood pressure
04/07/2010EP2170333A2 Ranolazine for elevated brain-type natriuretic peptide
04/07/2010EP2170306A1 Methods of treating serotonin-mediated diseases and disorders
04/07/2010EP2170105A1 Extract from palm leaves and a method for producing the same
04/07/2010EP2170090A2 Fortification of nutritional products with olive extracts containing hydroxytyrosol and hydroxytyrosol fortified nutritional products
04/07/2010EP2170065A1 Diphenyl substituted alkanes
04/07/2010EP2170059A1 Cetp inhibitors derived from benzoxazole arylamides
04/07/2010EP1322752B1 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof
04/07/2010EP1313499B1 Method for treating the central nervous system by administration of igf structural analogs
04/07/2010EP1175497B1 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
04/07/2010CN1970009B Chinese medicinal suppository for treating piles quickly
04/07/2010CN1879709B Chinese medicine for treating piles and anal fistula
04/07/2010CN1732952B Compound dispersible tablet for treating hypertension
04/07/2010CN1578647B Implantable and sealable system for unidirectional delivery of therapeutic agents to tissues
04/07/2010CN1569869B Chinese chestnut flower flavone compounds
04/07/2010CN101691351A Synthesis method of 4-aminopropenylphenyl-1,4-dihydropyridine and medicinal application thereof
04/07/2010CN101690816A Medicinal composition of calcium-containing antagonist, A II receptor antagonist and statins
04/07/2010CN101690795A Tianshen vessel-freeing granules for treating cardiovascular and cerebrovascular diseases
04/07/2010CN101690777A Formula of polygonatum chewable tablets and preparation method thereof
04/07/2010CN101690770A Preparation capable of reducing blood pressure and blood lipid and improving human immunity, and preparation method thereof
04/07/2010CN101690764A Traditional Chinese medicine for treating cardiac, cerebral and vascular diseases and preparation method thereof
04/07/2010CN101690762A Oral preparation for curing nerve ending diseases and Raynaud disease
04/07/2010CN101690754A Medicine for curing cerebral thrombosis sequela
04/07/2010CN101690748A Identification method of traditional Chinese medicine Shenfu cardiotonic pill
04/07/2010CN101690733A Leech enzymatic acetone powder enteric preparation and preparation method and application thereof
04/07/2010CN101690731A Application of umbilical cord Wharton jelly originated mesenchymal stem cells in heart failure cellular transplantation therapy
04/07/2010CN101690726A Natural activating agent of peroxisome proliferator activated receptor-gamma
04/07/2010CN101690725A Pharmaceutical composition for treating cardiovascular diseases and preparation method and use thereof
04/07/2010CN101690724A Piperazine ferulate enteric preparation and preparation method thereof
04/07/2010CN101690720A Carteolol orally disintegrating tablets and preparation method thereof
04/07/2010CN101690719A Bisulfate clopidogrel solid preparation, particles and preparation method thereof
04/07/2010CN101690718A Carteolol hydrochloride pellets, preparation method thereof and preparation thereof
04/07/2010CN101088548B Chinese medicine prepn for treating arrhythmia and its prepn process and quality control method
04/07/2010CN101032473B Sandwich type medical releasing film and preparing method thereof
04/07/2010CN101024038B Medicine composition with fat-clearing, blood-pressure-reducing functions
04/07/2010CN101023945B Use of non-periphery substituted phthalocyaniu metal complex
04/07/2010CN101011562B Novel formulation of shenqiwendan decoction and production method thereof
04/07/2010CN101002791B Traditional Chinese medicine composition for treating cerebrovascular disease, and its preparing method
04/06/2010US7692028 for treating neurological disorders such as epilepsy, neuropathic pain, bipolar disorder or migraine; 2-(2-oxo-4-propyl-1-pyrrolidinyl)butanamide; neuroprotective agent
04/06/2010US7691995 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes
04/06/2010US7691967 Smart pro-drugs of serine protease inhibitors
04/06/2010US7691883 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis
04/06/2010US7691858 3-(2,4-Diaminopteridin-6-yl)phenol or 6-(1H-Indol-4-yl)pteridine-2,4-diamine;phosphoinositide 3-kinase; enzyme inhibitors; vasculostatic agents; antiinflammatory agents; antiarthric agents; transplant rejecction; autoimmune diseases; anticarcinogenic agents
04/06/2010US7691854 Diethyl 2-amino-4-(4-cyanophenyl)-6-methyl-1-(3-methylphenyl)-1,4-dihydro-3,5-pyridine-dicarboxylate; chronic obstructive pulmonary disease, acute coronary syndrome, acute myocardial infarction or development of heart failure
04/06/2010US7691849 Carboxamidine derivatives and their use in the treatment of vascular diseases
04/06/2010US7691846 blood coagulation factor (trypsin-like serine protease enzymes) inhibitor; 1-(3-amino-1,2-benzisoxazol-5-yl)-5-{[5-(2-oxo-1-piperidinyl)-2,3-dihydro-1H-indol-1-yl]carbonyl}-1H-pyrazole-3-carboxamide; anticoagulant; cardiovascular thromboembolic disorder transient ischemic attack, stroke, atherosclerosis
04/06/2010US7691844 4-(2-fluorophenylbenzoyl-4-aminobenzoyl)-3'-(2-(N,N-dimethylaminoethylaminocarbonyl))-4-aza-[6,4]-spiro-[5,6]-benzoundec-2'-ene; inner ear disorders, hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure
04/06/2010US7691804 Administering formulation selected from a BAFF-R polypeptide or fragment; a chimeric molecule comprising a BAFF-R polypeptide or fragment fused to heterologous amino acid sequence; anti-BAFF-R antibody for inhibiting B-cell growth
04/06/2010US7691568 Antibody composition-containing medicament
04/06/2010US7691425 Method for manufacturing α-glycosylisoquercitrin, intermediate product and by-product thereof
04/06/2010US7691422 Oral compositions for the treatment of cellulite
04/06/2010US7691416 kit for administering a pharmaceutical composition that includes carbon monoxide to the patient in angioplasty procedures and for treating a donor, organ, and/or recipient with carbon monoxide during a transplantation procedure
04/06/2010CA2496712C New process for synthesizing derivatives of 1,3,4,5-tetrahydro-2h-3-benzazepin-2-one and its application to the synthesis of ivabradine and its pharmaceutically acceptable acid addition salts
04/06/2010CA2475137C New heterocyclic oxime derivatives, their preparation process and the pharmaceutical compositions that contain them
04/06/2010CA2464846C Dibenzylamine compounds and pharmaceutical use thereof
04/06/2010CA2453383C Piperidine derivatives as nmda receptor antagonists
04/06/2010CA2397636C Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
04/06/2010CA2358505C Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
04/06/2010CA2351709C Novel triazolo(4,5-d)pyrimidine compounds
04/06/2010CA2339182C Improvement of cardiac function by mesenchymal stem cell transplantation
04/01/2010WO2010037059A2 Heteroaryl antagonists of prostaglandin d2 receptors
04/01/2010WO2010037054A2 Heteroaryl antagonists of prostaglandin d2 receptors
04/01/2010WO2010037050A2 Synthesis of functionalized octahydro-isoquinolin-1-one-8-carboxamides, octahydro-isoquinolin-1-one-8-carboxylic esters and analogs, and therapeutic methods
04/01/2010WO2010036910A1 Heart protection by administering an amp-activated protein kinase activator
04/01/2010WO2010036111A1 Means and methods for counteracting, preventing and/or determining fibrosis or a risk of fibrosis
04/01/2010WO2010035806A1 Solid pharmaceutical composition
04/01/2010WO2010035769A1 Improved antibody molecule
04/01/2010WO2010035750A1 Method for producing lipid
04/01/2010WO2010035749A1 Method for concentrating lipid
04/01/2010WO2010035745A1 Heterocyclic biaryl derivative, and pde inhibitor comprising same as active ingredient
04/01/2010WO2010035253A1 Effective nitric oxide generating preparations
04/01/2010WO2010035221A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
04/01/2010WO2010035220A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
04/01/2010WO2010035217A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
04/01/2010WO2010035074A1 Use of nitrous oxide, argon, xenon, helium, or neon, for the manufacture of a pharmaceutical composition for treating ischemic insults in patients who cannot be treated with thrombolytic agents
04/01/2010WO2010035052A1 Tissue selective stearoyl-coa desaturase 1 inhibitors and cell based screening assay for their identification
04/01/2010WO2010035013A1 Krill oil powder and krill oil tablets
04/01/2010WO2010034707A1 Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators
04/01/2010WO2010034706A1 Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators
04/01/2010WO2010034269A1 Use of 2,5-dihydroxy-3,6-dimethylpyrazine and derivatives thereof in medicaments preparation
04/01/2010WO2010034212A1 Phenoxy acetic acid pyrazine ester derivatives, the preparation methods and uses thereof
04/01/2010WO2010034134A1 Preparation method of concentrated pill of chinese medicine
04/01/2010WO2010008864A3 Cycloalkane[b]indole angtagonists of prostaglandin d2 receptors
04/01/2010WO2009158007A3 Methods and compositions for therapeutic treatment
04/01/2010WO2009154944A3 Pharmaceutical formulations and methods of use which combine non-steroidal anti-inflammatory compounds with anti-hypertensive compounds
04/01/2010WO2009138762A3 Therapeutic use of peptides
04/01/2010WO2009125981A9 Pharmaceutical formulation
04/01/2010WO2008139845A8 Novel amide derivative
04/01/2010WO2008091618A8 Use of d-ribose to treat cardiac arrhythmias
1 ... 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 ... 1595